Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone and Alendronate in Hypogonadal Men
NCT01460654Phase 2Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- Oct 2011
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Testosterone TEPI patch, alendronate in Hypogonadism, osteoporosis, osteopenia, sponsored by Massachusetts General Hospital. Started Oct 2011; status: terminated.
02
Drugs
Testosterone TEPI patchalendronate
03
Conditions
Hypogonadismosteoporosisosteopenia
Beyond the preview
Go deeper on NCT01460654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01460654.